tiprankstipranks

Ann Merrifield Insider Profile

4 Followers
Ann Merrifield, Director at Flexion Therapeutics, holds 14.50K shares in Flexion Therapeutics (Ticker: FLXN), holds 3.64K shares in Invivo Therapeutics Holdings (Ticker: NVIV), holds 0.00 shares in Juniper Pharmaceuticals (Ticker: JNP).
tipranks
Ann Merrifield

Ann Merrifield
Flexion Therapeutics (FLXN)
Director

Ranked #69,380 out of 78,624 Corporate Insiders

Profitable Transactions

14%
1 out of 7 Profitable Transactions

Average Return

-25.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$159K
98.69%
1.31%
0.00%
A breakdown of Ann Merrifield's holdings

Insider Roles

Flexion Therapeutics
(FLXN)
Director
Invivo Therapeutics Holdings
(NVIV)
Director
Columbia Laboratories
(CBRX)
Director
Roles that Ann Merrifield holds in companies

Most Profitable Insider Trade

Stock:
Flexion Therapeutics
(FLXN)
Rating:Informative Buy
Date:Jun 16, 2016 - Jun 16, 2017
Return:+23.60%
The most profitable trade made by Ann Merrifield

Ann Merrifield's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Flexion Therapeutics
Jun 12, 2020
Director
Uninformative Buy
$156.89K
JNP
Juniper Pharmaceuticals
Aug 15, 2018
Uninformative Sell
277.18K
$0.00
Invivo Therapeutics Holdings
Mar 12, 2020
Director
Uninformative Buy
$2.08K
Columbia Laboratories
Director
List of latest transactions for each holding click on a transaction to see Ann Merrifield's performance on stock

Ann Merrifield insider profile FAQ

What is the percentage of profitable transactions made by Ann Merrifield?
The percentage of profitable transactions made by Ann Merrifield is 14%.
    What is the average return per transaction made by Ann Merrifield?
    The average return per transaction made by Ann Merrifield is -25.40%.
      What stocks does Ann Merrifield hold?
      Ann Merrifield holds: FLXN, JNP, NVIV, CBRX stocks.
        What was Ann Merrifield’s latest transaction?
        Ann Merrifield latest transaction was an Uninformative Buy of ―.
          What was Ann Merrifield's most profitable transaction?
          Ann Merrifield’s most profitable transaction was an Informative Buy of FLXN stock on June 16, 2016. The return on the trade was 23.60%.
            What is Ann Merrifield's role in Flexion Therapeutics?
            Ann Merrifield's role in Flexion Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.